1 citations
,
October 2020 in “IP Indian journal of clinical and experimental dermatology” This study investigates the potential correlation between serum ferritin levels and diffuse hair loss, but it reports no new clinical findings.
1 citations
,
October 2018 in “Madridge journal of dermatology & research” This resource outlines the focus areas of the Madridge Journal of Dermatology & Research and reports no new clinical findings.
1 citations
,
February 2014 in “Hair therapy & transplantation” This case report describes a 21-year-old woman experiencing acute hair loss and thinning, with no clear cause identified from her health history except polycystic ovary syndrome and family history of androgenetic alopecia.
1 citations
,
January 2014 in “International Journal of Trichology” This case report describes a 35-year-old woman with diffuse partial woolly hair occurring alongside epidermolysis bullosa with mottled pigmentation.
1 citations
,
January 1997 in “Dermatology” A woman lost her hair from stress after a bee attack and her sister's death.
1 citations
,
July 1996 in “Clinical and Experimental Dermatology” This article discusses the extent of investigation needed for diffuse alopecia in women but reports no new findings.
August 2026 in “Clinical Case Reports” In this case report, a patient with diffuse alopecia areata experienced complete hair regrowth after treatment with oral abrocitinib, with no adverse effects observed.
August 2026 in “Russian Journal of Skin and Venereal Diseases” In this prospective study, combining photodynamic therapy with PRP therapy significantly improved hair growth, quality of hair, and quality of life in women with acute telogen effluvium, compared to using each therapy alone.
June 2026 in “Skin Appendage Disorders” This review discusses diffuse unpatterned alopecia (DUPA) as an understudied variant of androgenetic alopecia, summarizing its presentation and management while calling for further research to better understand its distinct characteristics.
May 2026 in “Preprints.org” This study found that a supplement containing cystine, B vitamins, and minerals improved hair condition in 34 women with diffuse hair loss over six months, as evidenced by an increased anagen/telogen hair ratio, positive participant feedback, and no serious side effects.
This study observed that vitamin D deficiency is linked to a weakened immune system and may promote autoimmune inflammation in individuals with diffuse alopecia, where hair loss happens throughout the scalp.
March 2026 in “Frontiers in Medicine” This study reported that two male patients with diffuse unpatterned alopecia exhibited donor-area involvement in both the vertex and occiput, challenging the assumption of occipital stability for hair transplantation, and showed partial improvement following treatment with oral finasteride and topical minoxidil.
March 2026 in “Ukrains kyi Visnyk Psykhonevrolohii” In this study, female patients with mixed alopecia reported significantly lower quality of life compared to those with metabolic alopecia, with poorer psychological well-being and personal fulfillment, linked closely to mental maladaptation severity, suggesting a biopsychosocial treatment approach.
March 2026 in “International Journal of Research and Review” This clinical study found that Rosmarinum officinalis mother tincture significantly improved hair volume and density in individuals with diffuse hair loss by enhancing hair parameters measured through a hair shedding visual scale and ponytail thickness test.
January 2026 in “Dermatology Practical & Conceptual” This study reported that diffuse lichen planopilaris significantly impairs quality of life in Moroccan patients, with trichodynia and hair quality changes most affecting daily functioning and leisure activities.
January 2026 in “Medico Research Chronicles” This study reports a case where a young male experienced improved hair condition following individualized homeopathic treatment and integrative therapy after hair thinning post-COVID-19 infection, suggesting potential benefits of non-invasive approaches at Dr Batra’s.
January 2026 in “Journal of Hair Restoration and Regenerative Medicine” This review discusses methods to better identify unsafe donor areas in patients with diffuse unpatterned alopecia, emphasizing non-surgical management when specific diagnostic criteria are met, but reports no new clinical results.
January 2026 in “Elsevier eBooks”
September 2025 in “Cureus” In this case report, the researchers documented a rare instance of plica neuropathica, characterized by matted and twisted hair, occurring alongside diffuse alopecia, marking the first such documented association and emphasizing its diagnostic challenges in identifying causes of alopecia.
August 2025 in “Psychiatry Neurology and Medical Psychology” This study investigated psychosocial adaptation in women with diffuse alopecia, finding that adaptation disorders, particularly related to depression and anxiety, more significantly impacted psychosocial adaptation than the alopecia's origin, highlighting areas for targeted psychological intervention.
August 2025 in “Vestnik dermatologii i venerologii” In this article, the authors concluded that despite diverse causes of diffuse hair loss, modern therapies can effectively manage the condition without side effects, as demonstrated in two clinical cases of telogen effluvium.
May 2025 in “The Journal of Rheumatology” In this case report, a woman with unexplained hair loss and high ANA levels developed systemic lupus erythematosus, highlighting the importance of monitoring autoantibodies for early lupus detection and management.
May 2025 in “AlQalam Journal of Medical and Applied Sciences” In this study, researchers found that while low serum ferritin levels are common among women, there was no clear association between those low levels and diffuse hair loss in patients with female pattern hair loss and chronic telogen effluvium.
May 2025 in “International Journal of Research Publication and Reviews” This article reviews the causes and pathogenesis of telogen effluvium, a prevalent form of hair loss, but reports no new research findings.
March 2025 in “Meditsinskiy sovet = Medical Council” In this article, researchers explore the causes, diagnostic approaches, and treatment strategies for diffuse telogen alopecia, emphasizing the importance of identifying triggers such as stress and metabolic disorders to effectively manage this hair loss condition.
December 2024 in “Medical alphabet” This study concludes that a combined therapy of erbium laser, transcutaneous laser blood irradiation, and minoxidil had the greatest impact on improving microcirculation efficiency in patients with diffuse telogen effluvium.
November 2024 in “Fizioterapevt (Physiotherapist)” This study found that combining fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved the psycho-emotional state and quality of life in patients with diffuse telogen effluvium, performing better than individual treatments alone, as measured by the DIQOL index.
November 2024 in “Fizioterapevt (Physiotherapist)” In this study, a combined treatment method using fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved hair loss in patients with diffuse telogenetic alopecia compared to other treatments, showing a 36.9% improvement in mild cases and a 70.8% improvement in severe cases.
October 2024 in “Dermatology Practical & Conceptual” This study found that among Pakistani patients with diffuse hair fall, a significant 79.17% had vitamin D3 deficiency, suggesting that early recognition and treatment of this deficiency may help reduce hair loss.
September 2024 in “Cosmoderma” This case study reports a 20-year-old male with lifelong hair loss and unresponsive skin-colored papules, without other systemic abnormalities or similar family medical history.